Acquisitions - Molecular Assemblies (Details) - Molecular - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Jan. 23, 2025 |
Sep. 30, 2025 |
|
| Business Combination [Line Items] | ||
| Consideration transferred | $ 11.2 | |
| Indemnity and adjustment holdback | $ 2.0 | |
| Indemnity and adjustment holdback period | 6 months | |
| Payment of acquisition holdback | $ 2.0 |
| X | ||||||||||
- Definition Business Combination, Indemnity And Adjustment Holdback No definition available.
|
| X | ||||||||||
- Definition Business Combination, Indemnity And Adjustment Holdback, Period No definition available.
|
| X | ||||||||||
- Definition Payment Of Acquisition Contingent Consideration, Holdback No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|